PHYDUXON

Vaccine for human use; Immunostimulants; Pre-filled syringes for the treatment of cancer; Anticancer drug; Medicines for the treatment of cancer; Medicinal agent for the treatment of cancer; Biological preparations for the treatment of cancer; Blood for medical purposes; Vaccines; Adjuvants for medical purposes; Albuminous preparations for medical purposes; Pharmaceutical drugs for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Cells for medical purposes; Immunomodulatory Pharmaceutical preparations, namely, Immune cells for the treatment of cancer; Pharmaceuticals for testing the human immune system; Reagents for medical use; Culture media for cultivating cells